Detalhe da pesquisa
1.
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.
J Cell Physiol
; 233(8): 5642-5654, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29154447
2.
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.
Blood Cancer Discov
; 2(3): 216-225, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34164626
3.
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.
Oncotarget
; 9(24): 17199-17209, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682216
4.
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases.
Oncotarget
; 9(24): 17220-17237, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682218
5.
Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.
Oncotarget
; 9(24): 17238-17254, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682219
6.
Impact of physical exercise in cancer survivors during and after antineoplastic treatments.
Oncotarget
; 9(17): 14005-14034, 2018 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568412
7.
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model.
Mol Ther Nucleic Acids
; 11: 485-493, 2018 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29858083
8.
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines.
Oncotarget
; 8(14): 23213-23227, 2017 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390196
9.
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.
Oncotarget
; 7(48): 79842-79853, 2016 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821800
10.
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
Oncotarget
; 7(34): 55690-55703, 2016 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27494886
11.
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells.
Oncotarget
; 6(19): 17147-60, 2015 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26003166
12.
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
Oncotarget
; 6(9): 6597-610, 2015 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25788264